Gilead Sciences (GILD) Gross Margin (2009 - 2026)
Gilead Sciences posted quarterly Gross Margin of 79.24% for Q1 2026, up 234.0% year-on-year from 23.72% in Q1 2025, and little changed on a QoQ basis from 79.51% in Q4 2025.
Gilead Sciences (GILD) has 18 years of Gross Margin data on file, last reported at 79.24% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 234.0% year-over-year to 79.24%; the trailing twelve-month figure through Mar 2026 stood at 79.35% (up 107.0% YoY), and the FY2025 full-year result was 78.83%, up 57.0% from the prior year.
- Gross Margin for Q1 2026 stood at 79.24%, roughly flat from 79.51% in the prior quarter.
- Across five years, Gross Margin topped out at 81.11% in Q4 2022 and bottomed at 70.62% in Q4 2023.
- The 5-year median for Gross Margin is 78.39% (2022), against an average of 78.13%.
- The widest annual swing landed in 2022, when Gross Margin jumped 1737 bps; it then slumped 1049 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 81.11% in 2022, then decreased by 13 bps to 70.62% in 2023, then rose by 12 bps to 79.11% in 2024, then increased by 1 bps to 79.51% in 2025, then slipped by 0 bps to 79.24% in 2026.
- The last three Gross Margin figures came in at 79.24% (Q1 2026), 79.51% (Q4 2025), and 79.8% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 81.93% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 66.31% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 71.88% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 74.24% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 68.16% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 79.24% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -51.69% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 70.22% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.24% |
| Dec 31, 2025 | 79.51% |
| Sep 30, 2025 | 79.80% |
| Jun 30, 2025 | 78.81% |
| Mar 31, 2025 | 76.90% |
| Dec 31, 2024 | 79.11% |
| Sep 30, 2024 | 79.14% |
| Jun 30, 2024 | 77.80% |
| Mar 31, 2024 | 76.79% |
| Dec 31, 2023 | 70.62% |
| Sep 30, 2023 | 77.80% |
| Jun 30, 2023 | 78.15% |
| Mar 31, 2023 | 77.94% |
| Dec 31, 2022 | 81.11% |
| Sep 30, 2022 | 80.19% |
| Jun 30, 2022 | 76.96% |
| Mar 31, 2022 | 78.39% |
| Dec 31, 2021 | 63.74% |
| Sep 30, 2021 | 83.52% |
| Jun 30, 2021 | 77.64% |
| Mar 31, 2021 | 78.81% |
| Dec 31, 2020 | 81.16% |
| Sep 30, 2020 | 82.65% |
| Jun 30, 2020 | 79.31% |
| Mar 31, 2020 | 82.53% |
| Dec 31, 2019 | 71.37% |
| Sep 30, 2019 | 81.53% |
| Jun 30, 2019 | 82.41% |
| Mar 31, 2019 | 81.88% |
| Dec 31, 2018 | 72.91% |
| Sep 30, 2018 | 80.59% |
| Jun 30, 2018 | 78.82% |
| Mar 31, 2018 | 80.33% |
| Dec 31, 2017 | 78.89% |
| Sep 30, 2017 | 84.15% |
| Jun 30, 2017 | 84.23% |
| Mar 31, 2017 | 85.29% |
| Dec 31, 2016 | 85.31% |
| Sep 30, 2016 | 84.95% |
| Jun 30, 2016 | 88.89% |
| Mar 31, 2016 | 84.69% |
| Dec 31, 2015 | 87.51% |
| Sep 30, 2015 | 87.17% |
| Jun 30, 2015 | 87.89% |
| Mar 31, 2015 | 88.39% |
| Dec 31, 2014 | 85.47% |
| Sep 30, 2014 | 83.66% |
| Jun 30, 2014 | 85.85% |
| Mar 31, 2014 | 83.74% |
| Dec 31, 2013 | 72.50% |
| Sep 30, 2013 | 72.86% |
| Jun 30, 2013 | 71.29% |
| Mar 31, 2013 | 69.48% |
| Dec 31, 2012 | 73.90% |
| Sep 30, 2012 | 72.56% |
| Jun 30, 2012 | 70.84% |
| Mar 31, 2012 | 71.30% |
| Dec 31, 2011 | 73.44% |
| Sep 30, 2011 | 72.30% |
| Jun 30, 2011 | 70.45% |
| Mar 31, 2011 | 72.14% |
| Dec 31, 2010 | 75.17% |
| Sep 30, 2010 | 75.35% |
| Jun 30, 2010 | 76.36% |
| Mar 31, 2010 | 78.88% |
| Dec 31, 2009 | 76.71% |
| Sep 30, 2009 | 77.26% |
| Jun 30, 2009 | 76.75% |
| Mar 31, 2009 | 78.48% |